Skip to content
Open access

Risk-Adapted Atrial Fibrillation Monitoring after Embolic Stroke of Undetermined Source: A Population-Based Study

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

Findings support a risk-adapted approach to cardiac rhythm monitoring after ESUS, with patients with ESUS at markedly different risks of AFDAS identified as part of a risk-adapted diagnostic pathway for cardiac rhythm monitoring.

Abstract

Background: Atrial fibrillation detected after stroke (AFDAS) is frequently diagnosed after embolic stroke of undetermined source (ESUS) and has important implications for secondary stroke prevention. Although prediction scores have been proposed to identify patients at increased risk of AFDAS, prospective evidence supporting their implementation to guide rhythm monitoring in routine clinical practice is limited. Methods: In this prospective, population-based implementation cohort study, adults with ESUS were enrolled between January 2022 and December 2024 across all stroke centers in Styria, Austria. The Graz AF Risk Score was prospectively implemented as part of a risk-adapted diagnostic pathway for cardiac rhythm monitoring. Patients with a score [≥]4 were recommended for implantable loop recorder monitoring, whereas monitoring in those with scores <4 remained at the treating physician's discretion. The primary outcome was AFDAS detection; recurrent ischemic stroke and recurrent stroke etiology were secondary outcomes. Results: Among 784 patients (median age 73 years [IQR 64-80], 45.7% women), AFDAS was detected in 166 patients (21.2%) during a median follow-up of 26.3 months (IQR 20-34). AFDAS detection was substantially higher in patients with a Graz AF Risk Score [≥]4 than <4 (38.1% vs. 3.9%; p<0.001). After adjustment for age, sex and ILR monitoring, a score [≥]4 independently predicted AFDAS (HR 6.3, 95% CI 3.5-11.2; p<0.001) and recurrent ischemic stroke (HR 2.2, 95% CI 1.1-4.1; p=0.023). Only one recurrent stroke in patients with a score <4 was attributable to atrial fibrillation (AF) (1/18, 5.6%). Conclusions: Prospective implementation of the Graz AF Risk Score identified patients with ESUS at markedly different risks of AFDAS. A Graz AF Risk Score [≥]4 was also independently associated with recurrent ischemic stroke. These findings support a risk-adapted approach to cardiac rhythm monitoring after ESUS.

Read PDF

Similar papers

Open access Feb 2026

Artificial intelligence shows comparable or improved performance to traditional risk models in predicting atrial fibrillation after cryptogenic stroke

In patients with cryptogenic stroke receiving an ICM, the ECG-AI score showed modest discrimination for AF detection, outperforming CHA2DS2-VA and HAVOC, but not Brown ESUS-AF, which indicates a possible role for AI-driven ECG analysis in risk stratification.

F. Wouters, M. Barthels, J. Vranken et al. · 0 citations
Open access Aug 2026

Management of recurrent atrial fibrillation after catheter ablation: 5-year outcomes of repeat catheter ablation vs. antiarrhythmic therapy

Abstract Aims Recurrence of symptomatic atrial fibrillation (AF) after catheter ablation (CA) is not uncommon. However, real-world long-term data on clinical outcomes of rhythm control strategies in patients with recurrent AF after CA remain limited. Methods and results Using the TriNetX database, we identified adult p...

Yong Hao Yeo, H. Wong, A. Vignarajah et al. · 0 citations
Aug 2026

Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis.

Extracranial clinically relevant bleeding is common among patients with AF treated with OACs and may more accurately reflect the overall burden of bleeding than major bleeding alone, suggesting that additional unmeasured or unknown factors contribute to bleeding risk.

Deborah M. Siegal, Marc Carrier, M. Bahit et al. · 0 citations
Review Aug 2026

Device-Detected Atrial Fibrillation After ARTESiA and NOAH-AFNET 6: From Episode Burden to Net Clinical Benefit.

Device-detected atrial high-rate episodes and subclinical atrial fibrillation occupy an intermediate state between an electronic signal and clinically documented atrial fibrillation. ARTESiA showed that apixaban reduced stroke or systemic embolism compared with aspirin while increasing major bleeding. NOAH-AFNET 6 foun...

Jordan Llerena-Velastegui, Ruth Jimbo-Sotomayor, J. Chávez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.